Work

Redefining Interstitial Lung Disease Diagnosis Through the Bronchoscope

Year: 2026

Type: review

Abstract: TOPIC IMPORTANCE: Interstitial lung disease encompasses > 200 disorders characterized by lung parenchymal inflammation and fibrosis, presenting significant diagnostic challenges that often require invasive procedures with substantial morbidity and mortality risks. Diagnostic approaches have traditionally relied on surgical lung biopsy for definitive histopathologic evaluation, a procedure carrying a 1.7% to 3.6% mortality rate; however, its use has declined recently. Bronchoscopy offers a safer alternative that provides direct access to the lung microenvironment through bronchoalveolar lavage, tissue sampling, and airway visualization. REVIEW FINDINGS: Traditional bronchoscopic applications include cellular analysis of bronchoalveolar lavage fluid, which shows promise in differentiating hypersensitivity pneumonitis from idiopathic pulmonary fibrosis through lymphocyte percentages; however, limitations in sensitivity and specificity persist. Transbronchial lung cryobiopsy has emerged as a safer tissue sampling method with 0.0% to 0.3% mortality compared with surgical approaches, albeit with reduced diagnostic yield. Novel genomic classifiers using RNA sequencing from transbronchial biopsies demonstrate high specificity (92%) for identifying usual interstitial pneumonia patterns; however, sensitivity remains limited (68%). Advanced technologies including systems biology approaches through proteomics and metabolomics of bronchoalveolar lavage fluid reveal distinct molecular endotypes with differential survival trajectories, offering potential for personalized treatment strategies. Endobronchial optical coherence tomography provides real-time microscopic visualization with resolution exceeding high-resolution CT scan, enabling accurate diagnosis of fibrotic patterns with excellent concordance to surgical biopsy. SUMMARY: Emerging bronchoscopic technologies could represent a paradigm shift toward precision medicine in interstitial lung disease, potentially transforming diagnostic approaches while maintaining superior safety profiles compared with current invasive standards.

Source: CHEST Journal

DOI: 10.1016/j.chest.2026.06.041

Authors: Anthony Mok, Satomi Yamamoto, Logan Evans, Elizabeth R. Volkmann, Lida P. Hariri, Scott M. Matson